Harmonic Pharma has developped a unique approach to find new uses of safe drugs and natural extracts : polypharmacology. Our expertise is a powerful accelerator of R&D: as the toxicity is already thoroughly documented in the original indication, development will be less risky and access to market will be faster in the proposed novel use.
Michel Souchet – CEO
Harmonic Pharma is the very first company developing and applying the polypharmacology paradigm to respiratory health. The expertise of the company results from a breakthrough innovation combined with the use of safe drugs and compounds.
Since inception in 2009, Harmonic Pharma has successfully managed several million euros R&D programs, including the development of assets which have been patented in the field of respiratory health and are ready to be licensed out :
27 July 2015
Investment key factors: